Intervention Review

Ribavirin plus interferon versus interferon for chronic hepatitis C

  1. Jesper Brok*,
  2. Lise Lotte Gluud,
  3. Christian Gluud

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 31 MAR 2009

DOI: 10.1002/14651858.CD005445.pub2


How to Cite

Brok J, Gluud LL, Gluud C. Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD005445. DOI: 10.1002/14651858.CD005445.pub2.

Author Information

  1. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Jesper Brok, Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, DK-2100, Denmark. jbrok@ctu.rh.dk. jesperb5@hotmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

  1. Current Version

    Ribavirin plus interferon versus interferon for chronic hepatitis C

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD005445.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Ribavirin plus interferon versus interferon for chronic hepatitis C

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Article first published online: 20 APR 2005 | DOI: 10.1002/14651858.CD005445